Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

SG O' Brien; F Guilhot; RA Larson; I Gathmann; M Baccarani; F Cervantes; Jan Cornelissen; T Fischer; A Hochhaus; T Hughes; K Lechner; JL Nielsen; P Rousselot; J Reiffers; G Saglio; J Shepherd; B Simonsson; A Gratwohl; JM Goldman; H Kantarjian; K Taylor; G Verhoef; AE Bolton; R Capdeville; BJ Druker

doi:10.1056/NEJMoa022457

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

SG O' Brien
, F Guilhot
, RA Larson
, I Gathmann
, M Baccarani
, F Cervantes
, Jan Cornelissen
, T Fischer
, A Hochhaus
, T Hughes
, K Lechner
, JL Nielsen
, P Rousselot
, J Reiffers
, G Saglio
, J Shepherd
, B Simonsson
, A Gratwohl
, JM Goldman
, H Kantarjian

K Taylor, G Verhoef, AE Bolton, R Capdeville, BJ Druker

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

3284 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	994-1004
Number of pages	11
Journal	New England Journal of Medicine
Volume	348
DOIs	https://doi.org/10.1056/NEJMoa022457
Publication status	Published - 2003

Research programs

EMC MM-02-41-03

Access to Document

10.1056/NEJMoa022457

http://hdl.handle.net/1765/57034

Cite this

O' Brien, SG., Guilhot, F., Larson, RA., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J., Fischer, T., Hochhaus, A., Hughes, T., Lechner, K., Nielsen, JL., Rousselot, P., Reiffers, J., Saglio, G., Shepherd, J., Simonsson, B., Gratwohl, A., Goldman, JM., ... Druker, BJ. (2003). Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. New England Journal of Medicine, 348, 994-1004. https://doi.org/10.1056/NEJMoa022457

@article{6f1a83af729c4f59b5bc2b7f77a8708f,

title = "Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia",

author = "\{O' Brien\}, SG and F Guilhot and RA Larson and I Gathmann and M Baccarani and F Cervantes and Jan Cornelissen and T Fischer and A Hochhaus and T Hughes and K Lechner and JL Nielsen and P Rousselot and J Reiffers and G Saglio and J Shepherd and B Simonsson and A Gratwohl and JM Goldman and H Kantarjian and K Taylor and G Verhoef and AE Bolton and R Capdeville and BJ Druker",

year = "2003",

doi = "10.1056/NEJMoa022457",

language = "Undefined/Unknown",

volume = "348",

pages = "994--1004",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

}

O' Brien, SG, Guilhot, F, Larson, RA, Gathmann, I, Baccarani, M, Cervantes, F, Cornelissen, J, Fischer, T, Hochhaus, A, Hughes, T, Lechner, K, Nielsen, JL, Rousselot, P, Reiffers, J, Saglio, G, Shepherd, J, Simonsson, B, Gratwohl, A, Goldman, JM, Kantarjian, H, Taylor, K, Verhoef, G, Bolton, AE, Capdeville, R & Druker, BJ 2003, 'Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia', New England Journal of Medicine, vol. 348, pp. 994-1004. https://doi.org/10.1056/NEJMoa022457

TY - JOUR

T1 - Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

AU - O' Brien, SG

AU - Guilhot, F

AU - Larson, RA

AU - Gathmann, I

AU - Baccarani, M

AU - Cervantes, F

AU - Cornelissen, Jan

AU - Fischer, T

AU - Hochhaus, A

AU - Hughes, T

AU - Lechner, K

AU - Nielsen, JL

AU - Rousselot, P

AU - Reiffers, J

AU - Saglio, G

AU - Shepherd, J

AU - Simonsson, B

AU - Gratwohl, A

AU - Goldman, JM

AU - Kantarjian, H

AU - Taylor, K

AU - Verhoef, G

AU - Bolton, AE

AU - Capdeville, R

AU - Druker, BJ

PY - 2003

Y1 - 2003

U2 - 10.1056/NEJMoa022457

DO - 10.1056/NEJMoa022457

M3 - Article

C2 - 12637609

SN - 0028-4793

VL - 348

SP - 994

EP - 1004

JO - New England Journal of Medicine

JF - New England Journal of Medicine

ER -